The presence of PTK2 gene amplification was confirmed by CGH performed on 19 surgically resected HCCs, revealing that this mutation was detected in 26% of cases and exclusively in moderately-differentiated and poorly-differentiated tumours [51]. The gene discussed is PTK2; the disease is neoplasm.